Arielle Rounds
Psychiatric/Mental Health · Warwick, RINPI 1396372280
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.4% of the total across 676 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 22 manufacturers reported payments, led by AbbVie at 26.3% of the total. 2025 is the largest year on record at $3,543, 2.0 times the $1,751 reported in 2021. Among psychiatric/mental health clinicians in RI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 676 payments — averaging $21.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$4K
- Otsuka America Pharmaceutical, Inc.$1K
- Vanda Pharmaceuticals Inc.$1K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$1K
- Takeda Pharmaceuticals U.S.A., Inc.$1K
- Axsome Therapeutics, Inc.$1K
- plus $4K from 16 others
What the payments were for
- Food & beverage$14,45499%
- Education$881%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 158 | $3,822 |
| Otsuka America Pharmaceutical, Inc. | 72 | $1,420 |
| Vanda Pharmaceuticals Inc. | 56 | $1,416 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 60 | $1,257 |
| Takeda Pharmaceuticals U.S.A., Inc. | 73 | $1,195 |
| Axsome Therapeutics, Inc. | 39 | $1,058 |
| Alkermes, Inc. | 39 | $939 |
| Neurocrine Biosciences, Inc. | 27 | $665 |
| Corium, LLC | 31 | $558 |
| Lundbeck LLC | 24 | $396 |
| Collegium Pharmaceutical, Inc. | 14 | $323 |
| Teva Pharmaceuticals USA, Inc. | 16 | $288 |
| Tris Pharma Inc | 13 | $242 |
| Johnson & Johnson | 8 | $214 |
| Supernus Pharmaceuticals, Inc. | 12 | $202 |
| Sunovion Pharmaceuticals Inc. | 14 | $191 |
| Bausch Health US, LLC | 5 | $104 |
| Neos Therapeutics, LP | 6 | $97 |
| Idorsia Pharmaceuticals US Inc | 3 | $55 |
| Eisai Inc. | 3 | $46 |
| Almatica Pharma LLC | 2 | $32 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$14,542 in reported general payments places this provider in the 95th percentile of 196 psychiatric/mental health providers in Rhode Island.
See all psychiatric/mental health providers in Rhode Island →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Aripiprazole | 12 | $1,154 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 15 | $797 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 26 | $740 |
| Escitalopram Oxalate | 29 | $501 |
| Clonazepam | 59 | $409 |
| Fluoxetine Hcl | 12 | $211 |
| Sertraline Hcl | 17 | $185 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Almatica Pharma LLCSertraline Hcl | $32 | $18517 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 196 psychiatric/mental health providers in Rhode Island.
Other psychiatric/mental health in Warwick
- Katie ThayerWarwick$16K
- Deborah HorvitzWarwick$10K
- Alyssa KortschinskyWarwick$8K
- Mark GauthierWarwick$8K
- Sarah WeinreichWarwick$5K
- Cathy KennedyWarwick$4K
- Shaylah SpellmanWarwick$2K
- Brett MichelsonWarwick$1K
- Cindy PatrickWarwick$1K
- Samantha Shawn MarshBradford$639K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.